Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/JPRN-UMIN000000745
JPRN-UMIN000000745CompletedPhase 1

Phase I Radiation Dose Escalation Study using Four-dimensional Intensity Modulated Radiation Therapy for Locally Advanced Pancreatic Cancer - 4DIMRT-PI for LA-Pancreatic Cancer

Hokkaido University Hospital Dept. of Radiology Dept. of Internal Medicine Dept. of Medical Oncology Dept. of Surgical Oncology0 sites24 target enrollmentStarted: June 21, 2007Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Phase 1
Status
Completed
Sponsor
Enrollment
24
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
ot applicable to 80years-old (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •1. Gastric pr duodenal ulcer 2. Use of phenitoin, walfalin potasium, flusitosin 3. Plural effusion, ascitis 4. Active infection 5. Major comorbidities 6. Congnitive deterioration 7. Allegy to drug 8. Pregnancy 9. If doctor judged not feasible to enroll

Investigators

Sponsor
Hokkaido University Hospital Dept. of Radiology Dept. of Internal Medicine Dept. of Medical Oncology Dept. of Surgical Oncology

Similar Trials

Completed
Phase 1
Phase I radiaition dose escalation study of intensity-modulated radiotherapy with end-exhalation breath-hold technique, combined with full-dose gemcitabine for patients with locally advanced pancreatic cancer.Pancreatic cancer
JPRN-UMIN000004589Department of Therapeutic Radiology, Kyoto University Hospital18
Not yet recruiting
Phase 1
Radiotherapy in globlastoma (brain tumor) patients
CTRI/2019/05/019146one
Not yet recruiting
Not Applicable
Phase I study of radiotherapy dose escalation on the 18F-FDG-PET avid region of the primary tumor in locally advanced oropharynx and oral cavity tumors eligible for concurrent chemoradiation.Cancer of the mouth and throatoropharynx/oral cavity carcinoma`s10017991
NL-OMON33780Antoni van Leeuwenhoek Ziekenhuis30
Completed
Not Applicable
A Phase I, Dose Escalation Study on the Safety, Pharmacokinetics and Pharmacodynamics of Coagulation Factor VIIa (Recombinant) and its Comparability to NovoSeven® in Healthy Male Volunteers Pre-Treated with Fondaparinuxhaemophilia10064477
NL-OMON34613Centre for Human Drug Research36
Active, not recruiting
Phase 1
A clinical gene therapy study with hematopoietic stem cells for the treatment of patients suffering from a malignant neoplasm of the central nervous systemGlioblastoma Multiforme
EUCTR2018-001404-11-ITGENENTA SCIENCE SR21